Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease
about
Atorvastatin reduces plasma levels of chemokine (CXCL10) in patients with Crohn's disease.Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines.Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocationRole of TLR5 and flagella in bacillus intraocular infection.The altered tight junctions: an important gateway of bacterial translocation in cachexia patients with advanced gastric cancer.Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease.Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis.Characterization of lymphoid follicles with red ring signs as first manifestation of early Crohn's disease by conventional histopathology and confocal laser endomicroscopy.Innate and adaptive immunity interact to quench microbiome flagellar motility in the gutEpithelial apoptosis in mechanistically distinct methods of injury in the murine small intestinePharmacology and clinical potential of guanylyl cyclase C agonists in the treatment of ulcerative colitis.CD83+CCR7- dendritic cells accumulate in the subepithelial dome and internalize translocated Escherichia coli HB101 in the Peyer's patches of ileal Crohn's disease.Functional Characteristics of the Gut Microbiome in C57BL/6 Mice Differentially Susceptible to Plasmodium yoeliiResponse of gammadelta T Cells to plant-derived tannins.Overview of stem cell therapy for Crohn's disease.Overview of biologic therapy for Crohn's disease.The universe of immune deficiencies in Crohn's disease: a new viewpoint for an old disease?Crohn's disease: evidence for involvement of unregulated transcytosis in disease etio-pathogenesisBarrier dysfunction and bacterial uptake in the follicle-associated epithelium of ileal Crohn's disease.ADAM-15/metargidin mediates homotypic aggregation of human T lymphocytes and heterotypic interactions of T lymphocytes with intestinal epithelial cells.Pathogenic T cell subsets in allergic and chronic inflammatory bowel disorders.The effect of NOD2 on the microbiota in Crohn's disease.Loss of Desmoglein 2 Contributes to the Pathogenesis of Crohn's Disease.Emerging treatments in Neurogastroenterology: Perspectives of guanylyl cyclase C agonists use in functional gastrointestinal disorders and inflammatory bowel diseases.Ex vivo culture of intestinal crypt organoids as a model system for assessing cell death induction in intestinal epithelial cells and enteropathy.Stress induces more serious barrier dysfunction in follicle-associated epithelium than villus epithelium involving mast cells and protease-activated receptor-2.A human gut ecosystem protects against C. difficile disease by targeting TcdA.Anti-TNF-alpha antibody (infliximab) therapy supports the recovery of eNOS and VEGFR2 protein expression in endothelial cells.
P2860
Q33440583-3B6B10E0-AF4E-449D-BC6C-04072413D8BEQ33491056-2B0CE1B3-15BB-4B8E-809A-537DFDEC5461Q33553358-138BAFC7-B66E-4A8C-86DF-BB389F9266A7Q33799956-475A95C4-7664-4E73-8D37-6F53594B1C02Q33842314-470D979D-E6FA-4CF3-8BAC-7ABA9C35CC52Q33964919-76E30246-8ED9-407A-A912-8733F2D2310FQ34216810-F0B93203-8E20-411F-B1C4-62BA0A1346C1Q34342534-B1B6F6E3-43FB-47D3-B12A-DF2118EDEB14Q35044326-F656325A-640B-46F4-9A00-1EF20860E88EQ35746664-A94EAE1F-9309-4B54-A313-0AA58226680CQ36790193-6ADD6163-50F6-46DD-9E0F-642ED96001C6Q37073770-BE1B3109-69F1-424C-B22E-B580FE054E36Q37284860-AEC252D1-17C6-45E0-8A7D-8015025DB779Q37362470-D7D6D6DB-E851-468E-869F-F817F37B9B23Q37519645-A3F02939-376F-4E56-B25D-6AE0CB61CEC0Q37547257-764A63F6-2F90-47CE-A6C7-C5CD7252E623Q37760211-2FF8674B-E41A-4E7F-8B5B-8517143F84E8Q37862587-A9EA798A-F5DF-4BF5-AF6D-2A03A37F76C3Q38021501-22C2CD58-A417-47FF-A3B8-A7BDD1D1E016Q38302938-7BF80D17-5AA6-4C1B-ABCE-8546F747B0CDQ38665573-234CD4C4-ED12-4ADC-99EB-8FC1708DE8ECQ38795438-F65127BC-074D-4C8C-8C5E-3D52F7DAD4B5Q38859765-6AF741ED-98F6-4855-B0CD-A9CA09DDAE01Q39012302-DB2C0CDF-5298-4C79-9189-CE98A128F9F3Q40386319-AAB9562B-7873-4732-92F3-32ECAF97C351Q40973719-1EC4DCC5-7E92-4D3A-9426-4150FEDABB0BQ42101679-70BDE2D3-8B96-4D25-9824-131B5C0EC08AQ54365605-5177F7AA-DEA1-4735-A61A-77DC68A9345D
P2860
Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Mucosal integrity and barrier ...... rly lesions in Crohn's disease
@ast
Mucosal integrity and barrier ...... rly lesions in Crohn's disease
@en
type
label
Mucosal integrity and barrier ...... rly lesions in Crohn's disease
@ast
Mucosal integrity and barrier ...... rly lesions in Crohn's disease
@en
prefLabel
Mucosal integrity and barrier ...... rly lesions in Crohn's disease
@ast
Mucosal integrity and barrier ...... rly lesions in Crohn's disease
@en
P2860
P356
P1476
Mucosal integrity and barrier ...... rly lesions in Crohn's disease
@en
P2093
D S A Sanders
P2860
P304
P356
10.1136/JCP.2004.021840
P407
P577
2005-06-01T00:00:00Z